 Novel drug delivery platform DehydraTECH masks unwanted tastes, improves onset speed, increases bioavailability of active ingredients Cannabis is the current focus, but company eyeing massive markets such as nicotine and painkillers Currently working on using DehydraTECH to deliver antiviral drugs and help in the global fight against coronavirus What Lexaria Bioscience does: Lexaria Bioscience Corp CSE:LXX OTCMKTS:LXRP is a Canadian company with a patented technology that promises to change the way drugs are delivered into the body. The Kelowna, British Columbia-based company has developed and markets DehydraTECH, which masks unwanted tastes, improves onset speed and increases the bioavailability of active pharmaceutical ingredients in a simple and cost-effective platform. 